Fatal hepatotoxicity associated with troglitazone

被引:55
作者
Vella, A [1 ]
de Groen, PC [1 ]
Dinneen, SF [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
关键词
D O I
10.7326/0003-4819-129-12-199812150-00032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1080 / 1080
页数:1
相关论文
共 5 条
[1]   Esophagitis associated with the use of alendronate [J].
deGroen, PC ;
Lubbe, DF ;
Hirsch, LJ ;
Daifotis, A ;
Stephenson, W ;
Freedholm, D ;
PryorTillotson, S ;
Seleznick, MJ ;
Pinkas, H ;
Wang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1016-1021
[2]   Effect of troglitazone in insulin-treated patients with type II diabetes mellitus [J].
Schwartz, S ;
Raskin, P ;
Fonseca, V ;
Graveline, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :861-866
[3]   Update in endocrinology [J].
Whitcomb, RW .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (10) :871-871
[4]  
1998, PHYSICIANS DESK REFE, P2118
[5]  
1997, SCRIP, V2290, P15